GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Revenue per Share

Cangene (FRA:YGE) Revenue per Share : €1.30 (TTM As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene Revenue per Share?

Cangene's revenue per share for the three months ended in Oct. 2013 was €0.27. Cangene's revenue per share for the trailing twelve months (TTM) ended in Oct. 2013 was €1.30.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Cangene's Revenue per Share or its related term are showing as below:

FRA:YGE's 3-Year Revenue Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 3.6
* Ranked among companies with meaningful 3-Year Revenue Growth Rate only.

Cangene Revenue per Share Historical Data

The historical data trend for Cangene's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Revenue per Share Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.27 1.72 1.57 1.35 1.44

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.29 0.46 0.28 0.27

Competitive Comparison of Cangene's Revenue per Share

For the Biotechnology subindustry, Cangene's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's PS Ratio distribution charts can be found below:

* The bar in red indicates where Cangene's PS Ratio falls into.



Cangene Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Cangene's Revenue Per Share for the fiscal year that ended in Jul. 2013 is calculated as

Revenue Per Share (A: Jul. 2013 )=Revenue (A: Jul. 2013 )/Shares Outstanding (Diluted Average) (A: Jul. 2013 )
=97.269/67.342
=1.44

Cangene's Revenue Per Share for the quarter that ended in Oct. 2013 is calculated as

Revenue Per Share (Q: Oct. 2013 )=Revenue (Q: Oct. 2013 )/Shares Outstanding (Diluted Average) (Q: Oct. 2013 )
=18.043/66.747
=0.27

Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene  (FRA:YGE) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Cangene Revenue per Share Related Terms

Thank you for viewing the detailed overview of Cangene's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines